NO922936L - Fremstilling av fettsyremedikamenter - Google Patents

Fremstilling av fettsyremedikamenter

Info

Publication number
NO922936L
NO922936L NO92922936A NO922936A NO922936L NO 922936 L NO922936 L NO 922936L NO 92922936 A NO92922936 A NO 92922936A NO 922936 A NO922936 A NO 922936A NO 922936 L NO922936 L NO 922936L
Authority
NO
Norway
Prior art keywords
preparation
acid medicines
aids
fatic acid
fatic
Prior art date
Application number
NO92922936A
Other languages
English (en)
Other versions
NO922936D0 (no
Inventor
David Frederick Horrobin
Michael David Winther
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10698951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922936(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of NO922936D0 publication Critical patent/NO922936D0/no
Publication of NO922936L publication Critical patent/NO922936L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Anvendelse av en eller flere EFA'er fra n-6-serien og/- eller n-3-serien ved fremstilling av et medikament for lind- ring av symptomene på AIDS, forebygging av utvikling av AIDS eller utvikling av symptomer på AIDS hos HIV-infiserte perso- ner, og en fremgangsmåte for behandling av slike personer.
NO92922936A 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter NO922936L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116054A GB9116054D0 (en) 1991-07-24 1991-07-24 Preparation of fatty acid medicaments

Publications (2)

Publication Number Publication Date
NO922936D0 NO922936D0 (no) 1992-07-23
NO922936L true NO922936L (no) 1993-01-25

Family

ID=10698951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922936A NO922936L (no) 1991-07-24 1992-07-23 Fremstilling av fettsyremedikamenter

Country Status (12)

Country Link
EP (1) EP0524796B1 (no)
JP (1) JPH05194244A (no)
KR (1) KR930001902A (no)
AT (1) ATE120954T1 (no)
AU (1) AU1968992A (no)
CA (1) CA2073913A1 (no)
DE (1) DE69202019D1 (no)
FI (1) FI923357A (no)
GB (1) GB9116054D0 (no)
IE (1) IE922250A1 (no)
NO (1) NO922936L (no)
ZA (1) ZA925562B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
US5856149A (en) * 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
DE19611953A1 (de) * 1996-03-26 1997-10-02 Beiersdorf Ag Verwendung von ungesättigten Monocarbonsäuren gegen Superinfektionen
US7381413B1 (en) 1998-04-17 2008-06-03 University Of Vermont And State Agricultural College Methods and products related to metabolic interactions in disease
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
ES2209658B1 (es) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CN1972604B (zh) * 2004-06-22 2010-06-02 努特里希亚公司 Hiv患者中屏障完整性的提高
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
KR101451438B1 (ko) 2006-03-15 2014-10-15 산토리 홀딩스 가부시키가이샤 리보플라빈과 세사민류를 함유하는 조성물
US8557764B2 (en) 2007-01-26 2013-10-15 The Regents Of The University Of Colorado, A Body Corporate Methods of modulating immune function
CA2680751C (en) 2007-03-15 2016-01-26 Suntory Holdings Limited Use of dioxabicyclo[3.3.0]octane derivatives as anti-fatigue agents
CA2717788A1 (en) 2007-07-09 2009-01-15 Eastern Virginia Medical School Substituted nucleoside derivatives with antiviral and antimicrobial properties
JP2009073747A (ja) * 2007-09-19 2009-04-09 Suntory Ltd アラキドン酸を有効成分とする抗疲労剤
AU2008301694B2 (en) * 2007-09-19 2013-07-18 Suntory Holdings Limited Compositions Containing Sesamin-Class Compound(s) and Arachidonic Acid Class Compound(s)
WO2020077420A1 (en) * 2018-10-16 2020-04-23 MOREIRA, Nivaldo José Extract of jatropha curcas seed oil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen

Also Published As

Publication number Publication date
NO922936D0 (no) 1992-07-23
ATE120954T1 (de) 1995-04-15
IE922250A1 (en) 1993-01-27
ZA925562B (en) 1993-04-28
KR930001902A (ko) 1993-02-22
AU1968992A (en) 1993-01-28
FI923357A0 (fi) 1992-07-23
FI923357A (fi) 1993-01-25
DE69202019D1 (de) 1995-05-18
JPH05194244A (ja) 1993-08-03
EP0524796B1 (en) 1995-04-12
EP0524796A1 (en) 1993-01-27
GB9116054D0 (en) 1991-09-11
CA2073913A1 (en) 1993-01-25

Similar Documents

Publication Publication Date Title
NO922936D0 (no) Fremstilling av fettsyremedikamenter
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
TW273550B (no)
DK0459666T3 (da) Lægemidler mod impotens
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
NO862611D0 (no) Tann- og munnbehandlingspreparat.
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
KR950703360A (ko) 미코박테리아 바케로부터의 치료제 및 hiv감염에 대한 그의 사용(therapeutic agent from mycobacterrium vaccae and its use against hiv infection)
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
FR2663230B1 (fr) Dispositif d'hygiene et de traitement.
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
IT1216556B (it) Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
SE9403861D0 (sv) Novel medicinal use
FR2713087B1 (fr) Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
ATE96639T1 (de) Vakuum-zahnpflege und zahnbehandlungsgeraet.
OA09766A (en) "Treatment of anxiety in benzodiazepine-withdrawn patients".
FR2652502B1 (fr) Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.
SE8904189D0 (sv) Anordning foer straeckbehandling av en maenniskas rygg
RU94023697A (ru) Средство для лечения инфекционного токсикоза у детей раннего возраста
ITMO920002A0 (it) -strumenti e loro metodo di utilizzazione per l'insegnamento di tecniche medico chirurgiche e infermieristiche.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
NO900671L (no) Innretning for diagnostering og behandling av nesesykdommer.
BG94567A (en) Medicaments for the treatment of aids and method for its application
RU93044256A (ru) Способ лечения саркоидоза